2007Journal of psychiatryRequires access

A study of risperidone combining with paroxetine in the treatment of obsessive-compulsive disorder

Wang Xue-r

Open publisher page 0 citations

Abstract

ObjectiveTo explore the efficacy of risperidone combining with paroxetine in the treatment of obsessive-compulsive disorder.Methods A total of 53 outpatients who met the criteria of CCMD-3 for obsessive-compulsive disorder were assigned to therapeutic group and control group for 12 weeks. Therapeutic group were given risperidone combining with paroxetine, and control group given paroxetine only. The clinical effect was assessed with Y-BOCS at the end of 2~ nd ,4~ th ,8~ th and 12~ th .ResultsAfter treatment,the marked improvement rate and effective rate in therapeutic group were higher than those in control group.There were significant differences in the reduction rates of Y-BOCS total scores between two groups at the end of 2~ nd ,4~ th ,8~ th and 12~ th .ConclusionParoxetine combining with risperidone has better effect in the treatment of obsessive-compulsive disorder than panoetine only.Low dose risperidone is dn effective potentiation in the treatment of obsessive-compulsive disorder.

About this research paper

What this paper is about

ObjectiveTo explore the efficacy of risperidone combining with paroxetine in the treatment of obsessive-compulsive disorder.Methods A total of 53 outpatients who met the criteria of CCMD-3 for obsessive-compulsive disorder were assigned to therapeutic group and control group for 12 weeks. Therapeutic group were given risperidone combining with paroxetine, and control group given paroxetine only. The clinical effect was assessed with Y-BOCS at the end of 2~ nd ,4~ th ,8~ th and 12~ th .ResultsAfter treatment,the marked improvement rate and effective rate in therapeutic group were higher than those in control group.There were significant differences in the reduction rates of Y-BOCS total scores between two groups at the end of 2~ nd ,4~ th ,8~ th and 12~ th .ConclusionParoxetine combining with risperidone has better effect in the treatment of obsessive-compulsive disorder than panoetine only.Low dose risperidone is dn effective potentiation in the treatment of obsessive-compulsive disorder.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

ObjectiveTo explore the efficacy of risperidone combining with paroxetine in the treatment of obsessive-compulsive disorder.Methods A total of 53 outpatients who met the criteria of CCMD-3 for obsessive-compulsive disorder were assigned to therapeutic group and control group for 12 weeks. Therapeutic group were given risperidone combining with paroxetine, and control group given paroxetine only. The clinical effect was assessed with Y-BOCS at the end of 2~ nd ,4~ th ,8~ th and 12~ th .ResultsAfter treatment,the marked improvement rate and effective rate in therapeutic group were higher than those in control group.There were significant differences in the reduction rates of Y-BOCS total scores between two groups at the end of 2~ nd ,4~ th ,8~ th and 12~ th .ConclusionParoxetine combining with risperidone has better effect in the treatment of obsessive-compulsive disorder than panoetine only.Low dose risperidone is dn effective potentiation in the treatment of obsessive-compulsive disorder.

Key concepts: Risperidone, Paroxetine, Obsessive compulsive, Psychology, Therapeutic effect, Clinical efficacy, Psychiatry, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
A study of risperidone combining with paroxetine in the treatment of obsessive-compulsive disorder — Research Paper | ScholarLens